Medicina em FocoBook an appointment

PROCEDURES · HEALTH

Esketamine for depression: uses, administration and risks

Esketamine is a nasal spray medication used in adults with treatment-resistant depression or, together with an oral antidepressant, in adults with major depression and acute suicidal thoughts or behavior. A psychiatrist prescribes and monitors it, and each session involves spray administration followed by supervised observation at the healthcare facility.

When depression does not improve with treatments already tried, it is natural to look for other options, and understanding each one well is the first step.

Schedule an evaluation

What it is

Esketamine is one of the chemical forms that make up ketamine; esketamine nasal spray is not approved for use as an anesthetic. It works by blocking a glutamate receptor in the brain, the NMDA receptor.

It does not replace psychiatric follow-up: for treatment-resistant depression, it may be used alone or with an oral antidepressant; for symptoms involving suicidal thoughts, it is used with an oral antidepressant. Because it can cause drowsiness and an out-of-body feeling (dissociation), it is administered only in authorized healthcare settings, never at home.

Purpose

  • Depression that has not improved after at least two different antidepressants at adequate doses and for adequate durations, called treatment-resistant depression.
  • Depressive symptoms in adults with major depression and acute suicidal thoughts or behavior, together with an oral antidepressant and under psychiatric evaluation.
  • Adults only; for treatment-resistant depression, it may be used alone or with an oral antidepressant.

How it is done

It is administered at the healthcare facility. The person applies the spray into their own nose, with guidance and supervision from the team. Blood pressure is measured before and after administration.

After administration, the person remains under observation for at least 2 hours, until the team considers it safe to leave. The spray is not approved as an anesthetic, and it may be administered in an outpatient setting, such as a medical office or clinic.

For treatment-resistant depression, sessions are twice weekly at first; then once weekly and later every one or two weeks, depending on the psychiatrist's assessment. At the end of the initial phase, the psychiatrist evaluates whether there has been benefit and whether continuing is worthwhile.

Preparation

  • Psychiatric evaluation, including the history of antidepressants already tried, their doses and duration of use.
  • Evaluation of blood pressure and diseases of the heart and brain blood vessels before starting, to weigh benefits and risks.
  • Do not eat during the 2 hours before the session or drink liquids during the 30 minutes before, because nausea and vomiting may occur.
  • Arrange for a companion or someone else to take you home: you should not drive until the next day, after a night's sleep.
  • Report all medications you take, including vitamins and herbal products, and any history of alcohol, medication or other drug abuse or dependence.
  • The psychiatrist provides instructions for your case; always follow them.

Recovery

In studies, dissociation was temporary and occurred only on the day of administration. Even so, do not drive or operate machinery, and avoid activities requiring full attention until the next day, after a night's sleep.

The psychiatrist monitors the effect on mood and assesses benefit at the end of the first 4 weeks. Tell the team about everything you feel between sessions.

Risks and precautions

  • Feeling disconnected from your body or surroundings (dissociation), which was temporary in studies.
  • Dizziness, drowsiness, nausea and vomiting.
  • Temporary increase in blood pressure, lasting about 4 hours.
  • Headache.
  • Risk of abuse and misuse, which is why the medication is administered only in authorized healthcare settings.
  • It should not be used by anyone with an aneurysm or similar blood vessel disease, a malformation between arteries and veins, or a history of bleeding inside the brain; the doctor assesses this beforehand.

When to go to the emergency department after the procedure

  • Chest pain, shortness of breath or a sudden, very severe headache after the session.
  • Vision changes, seizure, reduced consciousness or weakness on one side of the body.
  • Thoughts of harming yourself or taking your own life: go to the emergency room or call SAMU (Brazil's emergency medical service) at 192 now.

In an emergency, call 192 (SAMU, Brazil's emergency medical service) or go to the nearest emergency room.

Alternatives

Other options for treatment-resistant depression include transcranial magnetic stimulation and electroconvulsive therapy. The psychiatrist discusses which options make sense for your case.

Frequently asked questions

Is esketamine the same as ketamine?

They are chemically related: esketamine is one of the forms that make up ketamine. Esketamine nasal spray is used to treat depression in adults and is not approved as an anesthetic.

How long does each session take?

Each session includes spray administration followed by at least 2 hours of observation, until the team considers it safe to leave. The exact time depends on the case.

Will I need to be hospitalized?

Not necessarily. It can be administered in an outpatient setting, such as a medical office or clinic. The team decides when you can leave, and someone needs to take you home.

Can I drive or work that day?

You should not drive or operate machinery after the session. Activities requiring full attention should also wait until the next day, after a night's sleep.

Will I become dependent?

There is a risk of abuse and misuse, which may lead to dependence. That is why it is administered only in authorized healthcare settings. Discuss this with your psychiatrist.

Does my health plan cover it?

It depends on your health plan and contract. Our team confirms coverage before starting.

Can an online consultation help?

An online consultation helps with initial evaluation, reviewing previous treatments and follow-up. Administration sessions take place in person in São Paulo.

Where we see patients

Rua Frei Caneca, 1380, térreo (Edifício Crystal Tower), Consolação, São Paulo-SP, CEP 01307-000, Brasil

Updated on